Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Quick facts

Phase 2 pipeline

• FCN-159 · Diabetes
  FCN-159 is a small molecule that targets the SGLT2 receptor.

Phase 1 pipeline

• FS-1502
• FXS887
• Luvometinib Tablets
• SAF-189s

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. portfolio CI brief
• Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. pipeline updates RSS